WT1 peptide vaccine induces reduction in minimal residual disease in an Imatinib-treated CML patient.
Oji Y, Oka Y, Nishida S, Tsuboi A, Kawakami M, Shirakata T, Takahashi K, Murao A, Nakajima H, Narita M, Takahashi M, Morita S, Sakamoto J, Tanaka T, Kawase I, Hosen N, Sugiyama H.
Oji Y, et al. Among authors: takahashi m, takahashi k.
Eur J Haematol. 2010 Oct;85(4):358-60. doi: 10.1111/j.1600-0609.2010.01497.x. Epub 2010 Aug 30.
Eur J Haematol. 2010.
PMID: 20633041